Gene therapy for PIDs: progress, pitfalls and prospects.

Authors:
Mukherjee S; Thrasher AJ.

Journal:
Gene

Publication Year: 2013

DOI:
10.1016/j.gene.2013.03.098

PMCID:
PMC3725417

PMID:
23566838

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Gene

Abbreviation: Gene

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics.
Arman K; Dalloul Z; Bozgeyik E. (2023) - Transparency Score: 3/6
From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants.
Papanikolaou V; Chrysovergis A; Ragos V and 10 more (2022) - Transparency Score: 3/6
Human T-lymphotropic virus type 1 and novel coronavirus disease 2019; More complex than just a simp…
Sajjadi S; Hejazi S; Ravanshad S and 1 more (2022) - Transparency Score: 2/6
In silico analysis of genomic landscape of SARS-CoV-2 and its variant of concerns (Delta and Omicro…
Saini S; Khurana S; Saini D and 7 more (2022) - Transparency Score: 4/6
Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection.
Wang Z; Zhong K; Wang G and 10 more (2022) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"The authors would like to thank the following funding agencies for their continued support: Wellcome Trust (UK), Great Ormond Street Hospital Children's Charity (UK), and the European Union 7th Framework Programme (PERSIST 222878)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025